RRML - Vitamin D receptor gene polymorphisms in multiple sclerosis disease: A case-control study
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2016): 55%

Română English


SCImago Journal & Country Rank


Advanced search


Top 10 downloaded articles
- August 2019 -
 
The Value of FLT3, NPM1 and DN... 9
Genotype comparison of Candida... 9
Simultaneous FLT3, NPM1 and DN... 8
Point-of-care testing in diabe... 7
Antiphospholipid syndrome – ... 7
Antibacterial activity of sele... 6
Vascular impact of quercetin a... 6
Arising Prevalence of OXA-48 p... 6
The utility of molecular genet... 5
To translate or not to transla... 5

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 26(4)/2018 DOI:10.2478/rrlm-2018-0028
XML
TXT

Research article

Vitamin D receptor gene polymorphisms in multiple sclerosis disease: A case-control study

Suat Cakina, Ozgul Ocak, Adile Ozkan, Selma Yucel, Handan Isin Ozisik Karaman

Correspondence should be addressed to: Suat Cakina

Abstract:

Multiple sclerosis (MS) is a common neurologic disorder that is a chronic inflammatory, demyelinating, and neurodegenerative disease of the central nervous system (CNS). Its etiology remains unknown. Several recent studies have found that decreased susceptibility to vitamin D deficiency is also associated with a decreased risk of MS. The role of vitamin D receptor (VDR) gene and its polymorphisms are highlighted as susceptible components. In this study, we aimed to identify the relationship between ApaI (rs7975232), BsmI (rs 1544410), and TaqI (rs731236) gene polymorphisms with MS. ApaI, BsmI, and TaqI genotypes were determined in 70 patients with MS and in 70 control subjects. DNA was isolated from blood samples, and then ApaI, BsmI and TaqI gene polymorphisms were identified using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. The distribution of BsmI and TaqI polymorphisms did not show any significant differences in MS patients and controls; however, increased A allele of ApaI polymorphism was found in MS patients. Our findings suggest that the ApaI gene polymorphism might be associated with MS. Investigation of a larger population and functional work on these gene structures and function in MS patients are recommended.

Keywords: multiple sclerosis, vitamin D, vitamin D receptor (VDR) gene polymorphism

Received: 5.3.2018
Accepted: 10.7.2018
Published: 22.7.2018

 
  PDF Download full text PDF
(373 KB)
     
 
How to cite
Cakina S, Ocak O, Ozkan A, Yucel S, Karaman HIO. Vitamin D receptor gene polymorphisms in multiple sclerosis disease: A case-control study. Rev Romana Med Lab. 2018;26(4):489-95. DOI:10.2478/rrlm-2018-0028